Oxidative and energy metabolism as potential clues for clinical heterogeneity in nucleotide excision repair disorders

Journal of Investigative Dermatology

Volumn 135, Issue 2, 2015, Pages 341-351

  Hosseini, Mohsen ^a,b   Ezzedine, Khaled ^a,b,c   Taieb, Alain ^a,b,c   Rezvani, Hamid Reza ^a,b,c  

^a Bordeaux Institute of Oncology   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; COCKAYNE SYNDROME GROUP A PROTEIN; COCKAYNE SYNDROME GROUP B PROTEIN; NUCLEIC ACID BINDING PROTEIN; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XERODERMA PIGMENTOSUM GROUP C PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XERODERMA PIGMENTOSUM GROUP G PROTEIN;

AEROBIC METABOLISM; ANTIOXIDANT ACTIVITY; CLINICAL FEATURE; CLINICAL OBSERVATION; COCKAYNE SYNDROME; COFS SYNDROME; DNA DAMAGE; ENERGY METABOLISM; EXCISION REPAIR; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENODERMATOSIS; HUMAN; MOLECULAR PATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PHOTOSENSITIVITY; PHOTOTHERAPY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RISK FACTOR; TRICHOTHIODYSTROPHY; ULTRAVIOLET RADIATION SENSITIVE SYNDROME; XERODERMA PIGMENTOSUM; DNA REPAIR; GENETICS; METABOLISM; OXIDATION REDUCTION REACTION; PHOTOSENSITIVITY DISORDER;

ANTIOXIDANTS; COCKAYNE SYNDROME; DNA REPAIR; ENERGY METABOLISM; HUMANS; OXIDATION-REDUCTION; PHOTOSENSITIVITY DISORDERS; TRICHOTHIODYSTROPHY SYNDROMES; XERODERMA PIGMENTOSUM;

EID: 84925357310     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.365     Document Type: Review

References (132)

1. Afaq F (2011) Natural agents: cellular and molecular mechanisms of photoprotection. Arch Biochem Biophys 508:144-51
2. Ahmad SI, Hanaoka F (2008) Molecular mechanisms of xeroderma pigmentosum. Preface. Adv Exp Med Biol 637:vii-xiv
3. Andressoo JO, Hoeijmakers JH, Mitchell JR (2006) Nucleotide excision repair disorders and the balance between cancer and aging. Cell Cycle 5:2886-8
4. Andressoo JO, Weeda G, de Wit J et al. (2009) An Xpb mouse model for combined xeroderma pigmentosum and cockayne syndrome reveals progeroid features upon further attenuation of DNA repair. Mol Cell Biol 29:1276-90
5. Arbault S, Sojic N, Bruce D et al. (2004) Oxidative stress in cancer prone xeroderma pigmentosum fibroblasts. Real-time and single cell monitoring of superoxide and nitric oxide production with microelectrodes. Carcinogenesis 25:509-15
6. Arczewska KD, Tomazella GG, Lindvall JM et al. (2013) Active transcriptomic and proteomic reprogramming in the C. elegans nucleotide excision repair mutant xpa-1. Nucleic Acids Res 41:5368-81
7. Austin S, St-Pierre J (2012) PGC1alpha and mitochondrial metabolism-emerging concepts and relevance in ageing and neurodegenerative disorders. J Cell Sci 125:4963-71
8. Berger F, Vaslin L, Belin L et al. (2013) The impact of single-nucleotide polymorphisms (SNPs) in OGG1 and XPC on the age at onset of Huntington disease. Mutat Res 755:115-9
9. Bernardes de Jesus BM, Bjoras M, Coin F et al. (2008) Dissection of the molecular defects caused by pathogenic mutations in the DNA repair factor XPC. Mol Cell Biol 28:7225-35
10. Bernerd F, Asselineau D, Frechet M et al. (2005) Reconstruction of DNA repair-deficient xeroderma pigmentosum skin in vitro: a model to study hypersensitivity to UV light. Photochem Photobiol 81:19-24
11. Berquist BR, Canugovi C, Sykora P et al. (2012) Human Cockayne syndrome B protein reciprocally communicates with mitochondrial proteins and promotes transcriptional elongation. Nucleic Acids Res 40:8392-405
12. Bessho T (1999) Nucleotide excision repair 3' endonuclease XPG stimulates the activity of base excision repairenzyme thymine glycol DNA glycosylase. Nucleic Acids Res 27:979-83
13. Bickers DR, Athar M (2006) Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol 126:2565-75
14. Bradford PT, Goldstein AM, Tamura D et al. (2011) Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet 48:168-76
15. Cadet J, Bourdat AG, D'Ham C et al. (2000) Oxidative base damage to DNA: specificity of base excision repair enzymes. Mutat Res 462:121-8
16. Canugovi C, Maynard S, Bayne AC et al. (2010) The mitochondrial transcription factor A functions in mitochondrial base excision repair. DNA Repair 9:1080-9
17. Capell BC, Tlougan BE, Orlow SJ (2009) From the rarest to the most common: insights from progeroid syndromes into skin cancer and aging. J Invest Dermatol 129:2340-50
18. Chen Z, Yang J, Wang G et al. (2007) Attenuated expression of xeroderma pigmentosum group C is associated with critical events in human bladder cancer carcinogenesis and progression. Cancer Res 67:4578-85
19. Cleaver JE (2005) Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nat Rev Cancer 5:564-73
20. Cleaver JE (2012) Photosensitivity syndrome brings to light a new transcriptioncoupled DNA repair cofactor. Nat Genet 44:477-8
21. Cleaver JE, Lam ET, Revet I (2009) Disorders of nucleotide excision repair: the genetic and molecular basis of heterogeneity. Nat Rev Genet 10:756-68
22. Cleaver JE, Thomas GH (1993) Clinical syndromes associated with DNA repair deficiency and enhanced sun sensitivity. Arch Dermatol 129:348-50
23. Cockayne EA (1936) Dwarfism with retinal atrophy and deafness. Arch Dis Child 11:1-8
24. Compe E, Egly JM (2012) TFIIH: when transcription met DNA repair. Nat Rev Mol Cell Biol 13:343-54
25. Cooper JM, Mann VM, Schapira AH (1992) Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: effect of ageing. J Neurol Sci 113:91-8
26. D'Errico M, Parlanti E, Teson M et al. (2006) New functions of XPC in the protection of human skin cells from oxidative damage. EMBO J 25:4305-15
27. D'Errico M, Parlanti E, Teson M et al. (2007) The role of CSA in the response to oxidative DNA damage in human cells. Oncogene 26:4336-43
28. de Verdier PJ, Sanyal S, Bermejo JL et al. (2010) Genotypes, haplotypes and diplotypes of three XPC polymorphisms in urinary-bladder cancer patients. Mutat Res 694:39-44
29. de Waard H, de Wit J, Andressoo JO et al. (2004) Different effects of CSA and CSB deficiency on sensitivity to oxidative DNA damage. Mol Cell Biol 24:7941-8
30. de Waard H, de Wit J, Gorgels TG et al. (2003) Cell type-specific hypersensitivity to oxidative damage in CSB and XPA mice. DNA Repair (Amst) 2:13-25
31. Dianov G, Bischoff C, Sunesen M et al. (1999) Repair of 8-oxoguanine in DNA is deficient in Cockayne syndrome group B cells. Nucleic Acids Res 27:1365-8
32. DiGiovanna JJ, Kraemer KH (2012) Shining a light on xeroderma pigmentosum. J Invest Dermatol 132:785-96
33. DiGiovanna JJ, Patronas N, Katz D et al. (1998) Xeroderma pigmentosum: spinal cord astrocytoma with 9-year survival after radiation and isotretinoin therapy. J Cutan Med Surg 2:153-8
34. Emmert S, Slor H, Busch DB et al. (2002) Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients. J Invset Dermatol 118:972-82
35. Fang EF, Scheibye-Knudsen M, Brace LE et al. (2014) Defective Mitophagy in XPA via PARP-1 Hyperactivation and NAD(+)/SIRT1 Reduction. Cell 157:882-96
36. Francisco G, Menezes PR, Eluf-Neto J et al. (2008) XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis. Eur J Hum Genet 16:724-34
37. Furda AM, Marrangoni AM, Lokshin A et al. (2012) Oxidants and not alkylating agents induce rapid mtDNA loss and mitochondrial dysfunction. DNA Repair 11:684-92
38. Giglia G, Dumaz N, Drougard C et al. (1998) p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C. Cancer Res 58:4402-9
39. Gillet LC, Scharer OD (2006) Molecular mechanisms of mammalian global genome nucleotide excision repair. Chem Rev 106:253-76
40. Gorgels TG, van der Pluijm I, Brandt RM et al. (2007) Retinal degeneration and ionizing radiation hypersensitivity in a mouse model for Cockayne syndrome. Mol Cell Biol 27:1433-41
41. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883-99
42. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646-74
43. Harada YN, Shiomi N, Koike M et al. (1999) Postnatal growth failure, short life span, and early onset of cellular senescence and subsequent immortalization in mice lacking the xeroderma pigmentosum group G gene. Mol Cell Biol 19:2366-72
44. Hashimoto S, Egly JM (2009) Trichothiodystrophy view from the molecular basis of DNA repair/transcription factor TFIIH. Hum Mol Genet 18:R224-30
45. Hayashi M, Araki S, Kohyama J et al. (2005) Oxidative nucleotide damage and superoxide dismutase expression in the brains of xeroderma pigmentosum group A and Cockayne syndrome. Brain Dev 27:34-8
46. He J, Shi TY, Zhu ML et al. (2013) Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis. Int J Cancer J Int Cancer 133:1765-75
47. Hoeijmakers JH (2009) DNA damage, aging, and cancer. N Engl J Med 361:1475-85
48. Hollander MC, Philburn RT, Patterson AD et al. (2005) Deletion of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis. Proc Natl Acad Sci USA 102:13200-5
49. Howell RR, Arbisser AI, Parsons DS et al. (1981) The Sabinas syndrome. Am J Hum Genet 33:957-67
50. Hsieh RH, Hou JH, Hsu HS et al. (1994) Age-dependent respiratory function decline and DNA deletions in human muscle mitochondria. Biochem Mol Biol Int 32:1009-22
51. Hu Z, Wang Y, Wang X et al. (2005) DNA repair gene XPC genotypes/ haplotypes and risk of lung cancer in a Chinese population. Int J Cancer 115:478-83
52. Itin PH, Sarasin A, Pittelkow MR (2001) Trichothiodystrophy: update on the sulfur-deficient brittle hair syndromes. J Am Acad Dermatol 44:891-920
53. Kamenisch Y, Fousteri M, Knoch J et al. (2010) Proteins of nucleotide and base excision repair pathways interact in mitochondria to protect from loss of subcutaneous fat, a hallmark of aging. J Exp Med 207:379-90
54. Kassam SN, Rainbow AJ (2007) Deficient base excision repair of oxidative DNA damage induced by methylene blue plus visible light in xeroderma pigmentosum group C fibroblasts. Biochem Biophys Res Commun 359:1004-9
55. Katiyar SK (2003) Skin photoprotection by green tea: antioxidant and immunomodulatory effects. Curr Drug Targets Immune Endocr Metabol Disord 3:234-42
56. Khan SG, Oh KS, Emmert S et al. (2009) XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms. DNA Repair 8:114-25
57. Klungland A, Hoss M, Gunz D et al. (1999) Base excision repair of oxidative DNA damage activated by XPG protein. Mol Cell 3:33-42
58. Koob M, Laugel V, Durand M et al. (2010) Neuroimaging in Cockayne syndrome. AJNR Am J Neuroradiol 31:1623-30
59. Kraemer KH, Lee MM, Andrews AD et al. (1994) The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 130:1018-21
60. Kraemer KH, Lee MM, Scotto J (1987) Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 123:241-50
61. Kulms D, Zeise E, Poppelmann B et al. (2002) DNA damage, death receptor activation and reactive oxygen species contribute to ultraviolet radiation-induced apoptosis in an essential and independent way. Oncogene 21:5844-51
62. Laugel V (2013) Cockayne syndrome: the expanding clinical and mutational spectrum. Mech Ageing Dev 134:161-70
63. Laugel V, Dalloz C, Tobias ES et al. (2008) Cerebro-oculo-facio-skeletal syndrome: three additional cases with CSB mutations, new diagnostic criteria and an approach to investigation. J Med Genet 45:564-71
64. Lee GY, Jang JS, Lee SY et al. (2005) XPC polymorphisms and lung cancer risk. Int J Cancer 115:807-13
65. Lesnefsky EJ, Hoppel CL (2006) Oxidative phosphorylation and aging. Ageing Res Rev 5:402-33
66. Lindenbaum Y, Dickson D, Rosenbaum P et al. (2001) Xeroderma pigmentosum/cockayne syndrome complex: first neuropathological study and review of eight other cases. Eur J Paediatr Neurol 5:225-42
67. Liu SY, Wen CY, Lee YJ et al. (2010) XPC silencing sensitizes glioma cells to arsenic trioxide via increased oxidative damage. Toxicol Sci 116:183-93
68. Low GK, Fok ED, Ting AP et al. (2008) Oxidative damage induced genotoxic effects in human fibroblasts from Xeroderma Pigmentosum group A patients. Int J Biochem Cell Biol 40:2583-95
69. Lu W, Hu Y, Chen G et al. (2012) Novel role of NOX in supporting aerobic glycolysis in cancer cells with mitochondrial dysfunction and as a potential target for cancer therapy. PLoS Biol 10:e1001326
70. Lubin A, Zhang L, Chen H et al. (2014) A human XPC protein interactome-a resource. Int J Mol Sci 15:141-58
71. Maalouf S, El-Sabban M, Darwiche N et al. (2002) Protective effect of vitamin E on ultraviolet B light-induced damage in keratinocytes. Mol Carcinog 34:121-30
72. Marchetto MC, Correa RG, Menck CF et al. (2006) Functional lentiviral vectors for xeroderma pigmentosum gene therapy. J Biotechnol 126:424-30
73. Maresca V, Flori E, Briganti S et al. (2008) Correlation between melanogenic and catalase activity in in vitro human melanocytes: a synergic strategy against oxidative stress. Pigment Cell Melanoma Res 21:200-5
74. -/- mice upon induction of oxidative stress. DNA Repair 12:1081-6
75. Melis JP, Wijnhoven SW, Beems RB et al. (2008) Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes. Cancer Res 68:1347-53
76. Menoni H, Hoeijmakers JH, Vermeulen W (2012) Nucleotide excision repair-initiating proteins bind to oxidative DNA lesions in vivo. J Cell Biol 199:1037-46
77. Miao F, Bouziane M, Dammann R et al. (2000) 3-Methyladenine-DNA glycosylase (MPG protein) interacts with human RAD23 proteins. J Biol Chem 275:28433-8
78. Miccoli L, Burr KL, Hickenbotham P et al. (2007) The combined effects of xeroderma pigmentosum C deficiency and mutagens on mutation rates in the mouse germ line. Cancer Res 67:4695-9
79. Morice-Picard F, Cario-Andre M, Rezvani H et al. (2009) New clinico-genetic classification of trichothiodystrophy. Am J Med Genet A 149A:2020-30
80. Moriwaki S, Kraemer KH (2001) Xeroderma pigmentosum-bridging a gap between clinic and laboratory. Photodermatol Photoimmunol Photomed 17:47-54
81. Moriwaki S, Stefanini M, Lehmann AR et al. (1996) DNA repair and ultraviolet mutagenesis in cells from a new patient with xeroderma pigmentosum group G and cockayne syndrome resemble xeroderma pigmentosum cells. J Invset Dermatol 107:647-53
82. Morley N, Curnow A, Salter L et al. (2003) N-acetyl-L-cysteine prevents DNA damage induced by UVA, UVB and visible radiation in human fibroblasts. J Photochem Photobiol B 72:55-60
83. Muftuoglu M, de Souza-Pinto NC, Dogan A et al. (2009) Cockayne syndrome group B protein stimulates repair of formamidopyrimidines by NEIL1 DNA glycosylase. J Biol Chem 284:9270-9
84. Muller-Hocker J (1989) Cytochrome-c-oxidase deficient cardiomyocytes in the human heart-an age-related phenomenon. A histochemical ultracytochemical study. Am J Pathol 134:1167-73
85. Muller-Hocker J, Seibel P, Schneiderbanger K et al. (1993) Different in situ hybridization patterns of mitochondrial DNA in cytochrome c oxidase-deficient extraocular muscle fibres in the elderly. Virchows Arch A Pathol Anat Histopathol 422:7-15
86. Nance MA, Berry SA (1992) Cockayne syndrome: review of 140 cases. Am J Med Genet 42:68-84
87. Nouspikel T, Clarkson SG (1994) Mutations that disable the DNA repair gene XPG in a xeroderma pigmentosum group G patient. Hum Mol Genet 3:963-7
88. Nouspikel T, Lalle P, Leadon SA et al. (1997) A common mutational pattern in Cockayne syndrome patients from xeroderma pigmentosum group G: implications for a second XPG function. Proc Natl Acad Sci USA 94:3116-21
89. Osenbroch PO, Auk-Emblem P, Halsne R et al. (2009) Accumulation of mitochondrial DNA damage and bioenergetic dysfunction in CSB defective cells. FEBS J 276:2811-21
90. Panich U, Tangsupa-a-nan V, Onkoksoong T et al. (2011) Inhibition of UVA-mediated melanogenesis by ascorbic acid through modulation of antioxidant defense and nitric oxide system. Arch Pharm Res 34:811-20
91. Park JY, Cho MO, Leonard S et al. (2008) Homeostatic imbalance between apoptosis and cell renewal in the liver of premature aging Xpd mice. PLoS ONE 3:e2346
92. Pascucci B, Lemma T, Iorio E et al. (2012) An altered redox balance mediates the hypersensitivity of Cockayne syndrome primary fibroblasts to oxidative stress. Aging Cell 11:520-9
93. Pelle E, Huang X, Mammone T et al. (2003) Ultraviolet-B-induced oxidative DNA base damage in primary normal human epidermal keratinocytes and inhibition by a hydroxyl radical scavenger. J Invest Dermatol 121:177-83
94. Pollitt RJ, Jenner FA, Davies M (1968) Sibs with mental and physical retardation and trichorrhexis nodosa with abnormal amino acid composition of the hair. Arch Dis Child 43:211-6
95. Price PA, Parthemore JG, Deftos LJ (1980) New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. J Clin Invest 66:878-83
96. Qiu L, Wang Z, Shi X (2008) Associations between XPC polymorphisms and risk of cancers: A meta-analysis. Eur J Cancer 44:2241-53
97. Quilliet X, Chevallier-Lagente O, Zeng L et al. (1997) Retroviral-mediated correction of DNA repair defect in xeroderma pigmentosum cells is associated with recovery of catalase activity. Mutat Res 385:235-42
98. Rezvani HR, Ali N, Nissen LJ et al. (2011a) HIF-1alpha in epidermis: oxygen sensing, cutaneous angiogenesis, cancer, and non-cancer disorders. J Invest Dermatol 131:1793-805
99. Rezvani HR, Cario-Andre M, Pain C et al. (2007a) Protection of normal human reconstructed epidermis from UV by catalase overexpression. Cancer Gene Ther 14:174-86
100. Rezvani HR, Dedieu S, North S et al. (2007b) Hypoxia-inducible factor-1alpha, a key factor in the keratinocyte response to UVB exposure. J Biol Chem 282:16413-22
101. Rezvani HR, Ged C, Bouadjar B et al. (2008) Catalase overexpression reduces UVB-induced apoptosis in a human xeroderma pigmentosum reconstructed epidermis. Cancer Gene Ther 15:241-51
102. Rezvani HR, Kim AL, Rossignol R et al. (2011b) XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas. J Clin Invest 121:195-211
103. Rezvani HR, Mazurier F, Cario-Andre M et al. (2006) Protective effects of catalase overexpression on UVB-induced apoptosis in normal human keratinocytes. J Biol Chem 281:17999-8007
104. Rezvani HR, Rossignol R, Ali N et al. (2011c) XPC silencing in normal human keratinocytes triggers metabolic alterations through NOX-1 activation-mediated reactive oxygen species. Biochim Biophys Acta 1807:609-19
105. Scharer OD (2008) XPG: its products and biological roles. Adv Exp Med Biol 637:83-92
106. Scheibye-Knudsen M, Ramamoorthy M, Sykora P et al. (2012) Cockayne syndrome group B protein prevents the accumulation of damaged mitochondria by promoting mitochondrial autophagy. J Exp Med 209:855-69
107. Schumacher B, Garinis GA, Hoeijmakers JH (2008) Age to survive: DNA damage and aging. Trends Genet 24:77-85
108. Seeberg E, Eide L, Bjoras M (1995) The base excision repair pathway. Trends Biochem Sci 20:391-7
109. Shimizu Y, Iwai S, Hanaoka F et al. (2003) Xeroderma pigmentosum group C protein interacts physically and functionally with thymine DNA glycosylase. EMBO J 22:164-73
110. Shiomi N, Kito S, Oyama M et al. (2004) Identification of the XPG region that causes the onset of Cockayne syndrome by using Xpg mutant mice generated by the cDNA-mediated knock-in method. Mol Cell Biol 24:3712-9
111. Shiomi N, Mori M, Kito S et al. (2005) Severe growth retardation and short life span of double-mutant mice lacking Xpa and exon 15 of Xpg. DNA Repair 4:351-7
112. Spivak G (2005) UV-sensitive syndrome. Mutat Res 577:162-9
113. Spivak G, Hanawalt PC (2006) Host cell reactivation of plasmids containing oxidative DNA lesions is defective in Cockayne syndrome but normal in UV-sensitive syndrome fibroblasts. DNA Repair 5:13-22
114. Stack EC, Matson WR, Ferrante RJ (2008) Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants. Ann N Y Acad Sci 1147:79-92
115. Sugiyama S, Takasawa M, Hayakawa M et al. (1993) Changes in skeletal muscle, heart and liver mitochondrial electron transport activities in rats and dogs of various ages. Biochem Mol Biol Int 30:937-44
116. Tanaka K, Sekiguchi M, Okada Y (1975) Restoration of ultraviolet-induced unscheduled DNA synthesis of xeroderma pigmentosum cells by the concomitant treatment with bacteriophage T4 endonuclease V and HVJ (Sendai virus). Proc Natl Acad Sci USA 72:4071-5
117. Thorslund T, von Kobbe C, Harrigan JA et al. (2005) Cooperation of the Cockayne syndrome group B protein and poly(ADP-ribose) polymerase 1 in the response to oxidative stress. Mol Cell Biol 25:7625-36
118. Tian M, Jones DA, Smith M et al. (2004) Deficiency in the nuclease activity of xeroderma pigmentosum G in mice leads to hypersensitivity to UV irradiation. Mol Cell Biol 24:2237-42
119. Tretter L, Adam-Vizi V (2000) Inhibition of Krebs cycle enzymes by hydrogen peroxide: A key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress. J Neurosci 20:8972-9
120. Tuo J, Jaruga P, Rodriguez H et al. (2002) The cockayne syndrome group B gene product is involved in cellular repair of 8-hydroxyadenine in DNA. J Biol Chem 277:30832-7
121. van der Pluijm I, Garinis GA, Brandt RM et al. (2007) Impaired genome maintenance suppresses the growth hormone-insulin-like growth factor 1 axis in mice with Cockayne syndrome. PLoS Biol 5:e2
122. Vineis P, Manuguerra M, Kavvoura FK et al. (2009) A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. J Natl Cancer Inst 101:24-36
123. von Hebra F, Kaposi M (1874) On Diseases of Skin Including the Exanthemata (Translated by W tay), Vol. 3. The New Sydenham Society: London
124. Vuillaume M, Daya-Grosjean L, Vincens P et al. (1992) Striking differences in cellular catalase activity between two DNA repair-deficient diseases: xeroderma pigmentosum and trichothiodystrophy. Carcinogenesis 13:321-8
125. Warrick E, Garcia M, Chagnoleau C et al. (2012) Preclinical corrective gene transfer in xeroderma pigmentosum human skin stem cells. Mol Ther 20:798-807
126. Wong HK, Muftuoglu M, Beck G et al. (2007) Cockayne syndrome B protein stimulates apurinic endonuclease 1 activity and protects against agents that introduce base excision repair intermediates. Nucleic Acids Res 35:4103-13
127. Xu P, Chen B, Feng J et al. (2012) Polymorphisms in XPC provide prognostic information in acute myeloid leukemia. Int J Hematol 96:450-60
128. Yao Y, Harrison KA, Al-Hassani M et al. (2012) Platelet-activating factor receptor agonists mediate xeroderma pigmentosum A photosensitivity. J Biol Chem 287:9311-21
129. Yarosh D, Klein J, O'Connor A et al. (2001) Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group. Lancet 357:926-9
130. Yen TC, Chen YS, King KL et al. (1989) Liver mitochondrial respiratory functions decline with age. Biochem Biophys Res Commun 165:944-1003
131. Zeng L, Quilliet X, Chevallier-Lagente O et al. (1997) Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C. Gene Ther 4:1077-84
132. Zhou NY, Bates SE, Bouziane M et al. (2003) Efficient repair of cyclobutane pyrimidine dimers at mutational hot spots is restored in complemented Xeroderma pigmentosum group C and trichothiodystrophy/xeroderma pigmentosum group D cells. J Mol Biol 332:337-51